Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer’s disease is safe
A treatment designed to eliminate pro-inflammatory senescent cells in Alzheimer’s disease was shown to be safe in a phase 1 clinical trial. …
A treatment designed to eliminate pro-inflammatory senescent cells in Alzheimer’s disease was shown to be safe in a phase 1 clinical trial. …
Scientists have created a promising injectable cell therapy to treat osteoarthritis that both reduces inflammation and also regenerates articular cartilage. …
End of content
End of content